Invention Grant
- Patent Title: Methods for characterizing loss of antigen presentation
-
Application No.: US16619761Application Date: 2018-06-01
-
Publication No.: US11920194B2Publication Date: 2024-03-05
- Inventor: Ugur Sahin , Martin Suchan , Barbara Schrörs , Martin Löwer , Petra Oehm
- Applicant: BioNTech RNA Pharmaceuticals GmbH , TRON—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainzgemeinnützige GmbH
- Applicant Address: DE Mainz
- Assignee: BioNTech SE,TRON—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz
- Current Assignee: BioNTech SE,TRON—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz
- Current Assignee Address: DE Mainz; DE Mainz
- Agency: Neal, Gerber & Eisenberg LLP
- Priority: WO TEP2017064112 2017.06.09
- International Application: PCT/EP2018/064479 2018.06.01
- International Announcement: WO2018/224406A 2018.12.13
- Date entered country: 2019-12-05
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12Q1/686 ; C12Q1/6876
Abstract:
This invention relates to methods for screening for a genotype for loss of antigen presentation via MHC class I in a subject and/or respectively detecting a subject's increased risk of resistance against immunotherapy such as against vaccination.
Information query
